IL-6 receptor antagonist monoclonal antibody

This page covers all IL-6 receptor antagonist monoclonal antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting IL-6R (Interleukin-6 receptor).

Targets

IL-6R (Interleukin-6 receptor)

Phase 3 pipeline (1)

• MIL62 · Beijing Mabworks Biotech Co., Ltd. · Immunology
  MIL62 is a monoclonal antibody targeting IL-6 receptor to inhibit interleukin-6 signaling and reduce inflammatory responses.